Magdalena C.
- Country
- Romania
- Department
- 6116: Pulmonology
Research Overview
- Efficacy and Safety Evaluation of Atuliflapon in Adults with Moderate-to-Severe Uncontrolled Asthma: A Phase 2a Randomized, Double-Blind, Placebo-Controlled Trial
- Efficacy and Safety Evaluation of Verekitug (UPB-101) in Moderate-to-Severe Chronic Obstructive Pulmonary Disease: A Phase 2b Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 18 of 167 partner sites.
Specializations
Respiratory Medicine
The investigator specializes in the treatment of severe eosinophilic asthma, focusing on innovative therapeutic approaches for patients with persistent respiratory conditions.
- Severe Asthma Management
- Eosinophilic Inflammation
- Respiratory Disease Control
Their research interests center on exploring new therapeutic options for patients with treatment-resistant asthma conditions.
Inflammatory Disorders
Dedicated to understanding and treating inflammatory airway diseases, with particular attention to eosinophil-mediated inflammation in respiratory conditions.
- Inflammatory Biomarkers
- Immune Response Modulation
- Eosinophil Biology
The investigator examines novel therapeutic approaches targeting specific inflammatory pathways in asthma.
Clinical Therapeutics
Focused on advancing treatment options for severe asthma patients, with emphasis on developing interventions for reducing asthma exacerbations.
- Exacerbation Prevention
- Treatment Optimization
- Long-term Disease Management
Their work encompasses evaluation of therapeutic interventions for patients with severe respiratory conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.